Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

175 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
An evaluation of 10 percent and 20 percent benzocaine gels in patients with acute toothaches: efficacy, tolerability and compliance with label dose administration directions.
Hersh EV, Ciancio SG, Kuperstein AS, Stoopler ET, Moore PA, Boynes SG, Levine SC, Casamassimo P, Leyva R, Mathew T, Shibly O, Creighton P, Jeffers GE, Corby PM, Turetzky SN, Papas A, Wallen J, Idzik-Starr C, Gordon SM. Hersh EV, et al. Among authors: papas a. J Am Dent Assoc. 2013 May;144(5):517-26. doi: 10.14219/jada.archive.2013.0154. J Am Dent Assoc. 2013. PMID: 23633700 Free PMC article. Clinical Trial.
Reversal of soft-tissue local anesthesia with phentolamine mesylate in pediatric patients.
Tavares M, Goodson JM, Studen-Pavlovich D, Yagiela JA, Navalta LA, Rogy S, Rutherford B, Gordon S, Papas AS; Soft Tissue Anesthesia Reversal Group. Tavares M, et al. Among authors: papas as. J Am Dent Assoc. 2008 Aug;139(8):1095-104. doi: 10.14219/jada.archive.2008.0312. J Am Dent Assoc. 2008. PMID: 18682624 Clinical Trial.
Outcomes of implants and restorations placed in general dental practices: a retrospective study by the Practitioners Engaged in Applied Research and Learning (PEARL) Network.
Da Silva JD, Kazimiroff J, Papas A, Curro FA, Thompson VP, Vena DA, Wu H, Collie D, Craig RG; Practitioners Engaged in Applied Research and Learning (PEARL) Network Group. Da Silva JD, et al. Among authors: papas a. J Am Dent Assoc. 2014 Jul;145(7):704-13. doi: 10.14219/jada.2014.27. J Am Dent Assoc. 2014. PMID: 24982276 Free PMC article.
Authors' response.
Da Silva JD, Kazimiroff J, Papas A, Curro FA, Thompson VP, Vena DA, Wu H, Collie D, Craig RG. Da Silva JD, et al. Among authors: papas a. J Am Dent Assoc. 2014 Oct;145(10):1013-4. doi: 10.1016/s0002-8177(14)60165-3. J Am Dent Assoc. 2014. PMID: 25270699 No abstract available.
Efficacy and safety of a novel mucoadhesive clobetasol patch for treatment of erosive oral lichen planus: A phase 2 randomized clinical trial.
Brennan MT, Madsen LS, Saunders DP, Napenas JJ, McCreary C, Ni Riordain R, Pedersen AML, Fedele S, Cook RJ, Abdelsayed R, Llopiz MT, Sankar V, Ryan K, Culton DA, Akhlef Y, Castillo F, Fernandez I, Jurge S, Kerr AR, McDuffie C, McGaw T, Mighell A, Sollecito TP, Schlieve T, Carrozzo M, Papas A, Bengtsson T, Al-Hashimi I, Burke L, Burkhart NW, Culshaw S, Desai B, Hansen J, Jensen P, Menné T, Patel PB, Thornhill M, Treister N, Ruzicka T. Brennan MT, et al. Among authors: papas a. J Oral Pathol Med. 2022 Jan;51(1):86-97. doi: 10.1111/jop.13270. Epub 2022 Jan 13. J Oral Pathol Med. 2022. PMID: 34907617 Clinical Trial.
A clinico-pathologic correlation. Pemphigus vulgaris.
Singh M, Demetriades N, Papas A, Gagari E. Singh M, et al. Among authors: papas a. J Mass Dent Soc. 2008 Winter;56(4):42-4. J Mass Dent Soc. 2008. PMID: 18459676 No abstract available.
Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sjögren's syndrome: a randomised, double-blind, placebo-controlled, phase 2b dose-finding trial.
Bowman SJ, Fox R, Dörner T, Mariette X, Papas A, Grader-Beck T, Fisher BA, Barcelos F, De Vita S, Schulze-Koops H, Moots RJ, Junge G, Woznicki JN, Sopala MA, Luo WL, Hueber W. Bowman SJ, et al. Among authors: papas a. Lancet. 2022 Jan 8;399(10320):161-171. doi: 10.1016/S0140-6736(21)02251-0. Epub 2021 Nov 30. Lancet. 2022. PMID: 34861168 Clinical Trial.
175 results